New Set of Monoclonal Antibodies to Gardnerella vaginalis Released

Laboratory products

New Set of Monoclonal Antibodies to Gardnerella vaginalis Released

03 Jul, 2019

Published over 7 years ago. See the latest and most current information on Laboratory products.

Gardnerella vaginalis is a major species present in bacterial vaginosis. It is a small gram variable, anaerobic coccobacillus. Overgrowth of this bacterium occurs due to an imbalance of normal vaginal flora which can result from prescription antibiotics. 

Microscopic evaluation often shows this bacterium associated with epithelial ‘clue cells’. Treatment with metronidazole or clindamycin is recommended.

ViroStat has just released a set of new monoclonal antibodies to Gardnerella vaginalis. These specific antibodies do not cross react with other agents including Chlamydia, Candida albicans and Neisseria gonorrhoeae. Several of the antibodies function as pairs in ELISA and lateral flow immunoassay for antigen detection.

Download the data sheets for these antibodies today or click here for further information.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
DC’s July fireworks pollution spike exposes limits of annual air quality standards
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Predictive maintenance advances in refineries as retrofit sensors mature
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow